KRATIUM

This brand name is authorized in Cyprus, Hong Kong SAR China, Malta.

Active ingredients

The drug KRATIUM contains one active pharmaceutical ingredient (API):

1	Diazepam UNII Q3JTX2Q7TU - DIAZEPAM
	Diazepam is a psychotropic substance from the class of 1,4-benzodiazepines with marked properties of suppression of tension, agitation and anxiety as well as sedative and hypnotic effects. In addition, diazepam demonstrates muscle relaxant and anticonvulsive properties. It is used in the short-term treatment of anxiety and tension states, as a sedative and premedicant, in the control of muscle spasm and in the management of alcohol withdrawal symptoms.
	Read more about Diazepam

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
KRATIUM Tablet	MPI, EU: SmPC	Υπουργείο Υγείας (CY)
KRATIUM Solution for injection/infusion	MPI, EU: SmPC	Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05BA01	Diazepam	N Nervous system → N05 Psycholeptics → N05B Anxiolytics → N05BA Benzodiazepine derivatives
Discover more medicines within N05BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
HK	Department of Health Drug Office	20529, 32481, 32730
MT	Medicines Authority	AA032/11001